Substances with vigorous DPP-IV inhibitory activity achieve hypoglycemia by inhibiting the effects of GLP-1 degradation, prolonging gastric emptying time and decreasing appetite in T2DM patients [20]. Here, GCG is linked to type 2 diabetes mellitus.